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In an effort to probe for metal binding to metallo-β-lactamase (MβL) IMP-1, the enzyme was overexpressed, 
purified, and characterized. The resulting enzyme was shown to bind 2 equiv of Zn(II), exhibit significant catalytic 
activity, and yield EXAFS results similar to crystallographic data previously reported. Rapid kinetic studies 
showed that IMP-1 does not stabilize a nitrocefin-derived reaction intermediate; rather, the enzyme follows a 
simple Michaelis mechanism to hydrolyze nitrocefin. Metal-substituted and metal-reconstituted analogues of 
IMP-1 were prepared by directly adding metal ion stocks to metal-free enzyme, which was generated by dialysis 
versus EDTA. UV–vis studies on IMP-1 containing 1 equiv of Co(II) showed a strong ligand-to-metal charge 
transition at 340 nm, and the intensity of this feature increased when the second equivalent of Co(II) was added 
to the enzyme. EXAFS fits on IMP-1 containing 1 equiv of Co(II) strongly suggest the presence of a metal–metal 
interaction, and EPR spectra of the IMP-1 containing 1 and 2 equiv of Co(II) are very similar. Taken together, 
steady-state kinetic and spectroscopic studies suggest that metal binding to metal-free IMP-1 follows a positive-
cooperative mode. 
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Due to the misuse of carbapenems and extended-spectrum cephalosporins, acquired metallo-β-lactamases 
(MβLs) are emerging in Gram-negative pathogens, including Acinetobacter spp. and Pseudomonas 
aeruginosa.(1-3) A large number of acquired MβLs have been identified during the past few years, including 
IMP-1, VIM-1, GIM-1, SPM-1, NDM-1, and SIM-1.(1, 4) The spread of resistance is not merely shared among 
species but extends into different genera via horizontal gene transfer. This scenario is exemplified by metallo-β-
lactamase IMP-1, which was initially isolated in the early 1990s from Pseudomonas aeruginosa and Serratia 
marcescens.(5, 6) Since this time, the blaIMP-1 gene has also been detected in isolates of Klebsiella pneumoniae, 
Pseudomonas putida, Alcaligenes xylosoxidans, Acinetobacter junii, Providencia rettgeri, Acinetobacter 
baumannii, and Enterobacter aerogenes.(1) Many of the plasmids containing the blaIMP-1 gene also encode for 
additional antibiotic resistance mechanisms, i.e., aminoglycosidase.(7) Because of the ability of the blaIMP gene 
to spread rapidly by horizontal transfer, isolates have been identified in South East Asia, Europe, and the 
Americas.(3, 8) 
To date, 27 variants of IMP-1 have been isolated from around the world.(8) Biochemical characterization of 
these variants has revealed structural and functional differences. Three minor variants of IMP-1 have been 
identified and called IMP-3,(9) IMP-6,(10) and IMP-10.(11) The most divergent is IMP-12 possessing 36 different 
amino acids.(12) The IMP enzymes exhibit broad substrate specificity, with high affinities for cephalosporins and 
carbapenems rather than for penicillins.(1, 8) By far, the best studied variant is IMP-1, which belongs to the B1 
subclass of MβLs.(13) Crystal structures of IMP-1 show an αβ/αβ sandwich fold, wherein the catalytic dinuclear 
zinc-binding site lies at the interface of the two αβ domains.(14-16) One Zn(II) (Zn1 site) is coordinated by 
His116, His119, His196, and a bridging water/hydroxide, while the second Zn(II) (Zn2 site) is bound by Asp120, 
Cys221, His263, a terminally bound water, and the bridging solvent molecule. The Zn(II)–Zn(II) distance is 3.5–
3.7 Å. 
Several of the MβLs (Zn(II)-containing and Co(II)-substituted forms) have been extensively studied using various 
spectroscopic techniques, such as 1H NMR, UV–vis, EPR, and EXAFS spectroscopies.(17-23) However, the number 
of spectroscopic studies on IMP-1 or any of the IMP variants is relatively small. Metallo-β-lactamase IMP-1 is 
considered to be one of the most clinically important MβLs for several reasons: (i) most IMP variants hydrolyze 
all β-lactam containing antibiotics, except monobactams, including carbapenems like imipenem; (ii) the gene for 
IMP, blaIMP-1 has rapidly spread in many pathogenic bacteria; and (iii) IMP has mutated to at least 27 different 
variants, each exhibiting different hydrolysis rates, stabilities, etc. This paper describes our efforts at preparing 
and characterizing Co(II)-substituted IMP-1. These studies will allow for the future use of rapid-freeze quench 
spectroscopic studies to probe the active site structures and mechanisms of IMP-1 and the IMP variants. 
Experimental Procedures 
Materials 
The pet26b-IMP-1 plasmid (originally isolated from clinical strain of Serratia marcescens producing IMP-1) was a 
gift from Dr. James Spencer (Department of Cellular and Molecular Medicine, University of Bristol, School of 
Medical Sciences, University Walk, Bristol BS8 1TD, U.K.). E. coli BL21(DE3) was used for the overexpression of 
IMP-1 via the T7 expression system (Novagen Inc., Madison, WI). IMP-1 was overexpressed in Luria–Bertani 
medium (LB) purchased from Invitrogen (Carlsbad, CA) or in minimum medium, as previously 
reported.(20) Isopropyl β-d-thiogalactoside (IPTG) was purchased from Anatrace (Maumee, OH). Recombinant 
IMP-1 was purified on a SP-Sepharose column (GE Healthcare). Purified protein solutions were concentrated 
with an Amicon ultrafiltration cell equipped with YM-10 DIAFLO membranes from Amicon, Inc. (Beverly, MA). 
Kinetic studies were conducted using nitrocefin purchased from Becton Dickinson (Franklin Lakes, NJ).(24) 
Overexpression and Purification of IMP-1 in Rich Medium 
To obtain large quantities of IMP-1, a 50 mL preculture of E. coli BL21(DE3) harboring the pet26b-IMP-1 plasmid 
was used to inoculate 4 × 1 L of Luria–Bertani (LB) medium. Kanamycin (25 μg/mL) was used as a selection agent 
during overexpression. The innoculum was grown at 37 °C until the culture reached an optical density (OD600 nm) 
of 0.8–1.0. Protein production was induced by making the cultures 0.5 mM in isopropyl-β-d-
thiogalactopyranoside (IPTG). The cultures were further incubated overnight at 22 °C for ∼20 h. Cells were 
collected by centrifugation (8000g) for 10 min. The resulting pellet was resuspended in 25 mL of 50 mM 4-(2-
hydroxymethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.5 (buffer A). The cells were lysed by passing the 
resuspended cells through a French Press three times at a pressures between 3.5 and 7.0 MPa. The lysate was 
clarified by centrifugation at 15000g for 30 min. The supernatant was dialyzed versus 1 L of 50 mM HEPES, pH 
7.5, overnight at 4 °C. To remove pre cipated protein and other insoluble components, the dialyzed sample was 
centrifuged for 30 min at 15000g. The sample solution was loaded onto an SP-Sepharose column (1.5 × 12 cm 
with a 25 mL bed volume), which was pre-equilibrated in 50 mM HEPES, pH 7.5. Bound proteins were eluted 
with 0–500 mM NaCl gradient in 50 mM HEPES, pH 7.5 (buffer B). Purity of the fractions was ascertained by SDS-
PAGE gels. Those fractions containing pure IMP-1 were pooled and concentrated by using an Amicon 
ultrafiltration concentrator equipped with a YM-10 membrane. IMP-1 concentrations were determined using 
the extinction coefficient (ε280 nm = 49 000 M–1 cm–1), as reported by Yamaguchi et al.(16) The extinction 
coefficient for all Zn(II)- and Co(II)-containing analogues of IMP-1 and for apo-IMP-1 was also found to be 49 000 
M–1 cm–1. 
Metal Analyses 
Inductively coupled plasma atomic emission spectroscopy (ICP-AES) was used to determine the metal content of 
IMP-1 samples. Purified enzyme samples were diluted to ∼10 μM in 50 mM HEPES, pH 6.8 or 7.5. Calibration 
curves exhibiting correlation coefficients of greater than 0.9999 were generated using serial dilutions of Fisher 
metal standards (Zn, Co, Cu, Fe, Mn, and Ni) ranging from 3.0 to 35 μM. Emission lines at 213.856, 238.892, 
324.754, 259.940, 257.610, and 231.604 nm were chosen to ensure the lowest possible detection limits for zinc, 
cobalt, copper, iron, manganese, and nickel, respectively. 
Steady-State Kinetics 
Steady-state kinetic studies were conducted on a Hewlett-Packard 5480A UV–vis spectrophotometer at 25 °C. 
The hydrolysis of nitrocefin by IMP-1 was monitored by following the formation of the hydrolyzed product at 
485 nm. The molar absorptivity of nitrocefin (Δε485 nm = 17 400 M–1 cm–1)(25) was used to determine the rates of 
hydrolysis. Substrate concentrations ranged from 10 to 200 μM or until significant substrate inhibition was 
observed. The enzyme concentration in the reactions was ca. 3 nM. All reactions were performed in 50 mM 
HEPES, pH 6.8 or 7.5, with total volume of 1 mL. 
Stopped-Flow Kinetic Studies 
To probe the reaction mechanism, stopped-flow UV–vis studies were conducted on an Applied Photophysics 
SX.18-MVR stopped-flow spectrophotometer at 4 °C. UV–vis spectra were recorded from 300 to 700 nm. Near 
single-turnover reactions were conducted with the use of 1:1 ratio of IMP-1:nitrocefin. Progress curves 
(absorbance change over time) from stopped-flow studies were converted to concentration of nitrocefin or 
concentration of hydrolyzed nitrocefin versus time by using the molar extinction coefficients of nitrocefin and 
hydrolyzed nitrocefin, respectively. Experiments were conducted in triplicate, and the data from the 
experiments were averaged. Simulated progress curves were generated by using a MATLAB script derived for 
three possible mechanisms (Scheme 1). The theoretical kcat and Km expressions for each mechanism were 
derived using the King– Altman method,(26) assuming k2 (or k3 in (2)) as the rate-limiting step. Rate constants 
were varied to fit the simulated curves to experimental presteady state data and to calculated 
“theoretical” kcat and Km values that matched experimental values. The rate constants for the binding of 




Samples of IMP-1 with 1 or 2 added equivalents of Zn(II) or Co(II) (0.8–1.5 mM) were prepared containing ca. 
30% (v/v) glycerol as glassing agent, loaded into Lucite cuvettes with 6 μm polypropylene windows, and flash 
frozen in liquid nitrogen. X-ray absorption spectra were measured at the National Synchrotron Light Source 
(NSLS), beamline X3B, using a Si(111) double crystal monochromator; harmonic rejection was accomplished 
using a Ni focusing mirror. Fluorescence excitation spectra were measured with a 13-element solid-state Ge 
array detector. Samples were held at ∼15 K in a Displex cryostat during XAS measurements. X-ray energies were 
calibrated by reference to the absorption spectrum of the appropriate metal foil, measured concurrently with 
the protein spectra. All of the data shown represent the average of ∼12 total scans, from two independently 
prepared samples for each stoichiometry. Data collection and reduction were performed according to published 
procedures(21, 27) with E0 set to 9675 eV for Zn and 7730 eV for Co. The Fourier-filtered EXAFS were fitted to 
eq 1 using the nonlinear least-squares engine of IFEFFIT that is distributed with SixPack(28) Sixpack is available 
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(1) 
In eq 1, Nas is the number of scattering atoms within a given radius (Ras, ±σas), As(k) is the backscattering 
amplitude of the absorber–scatterer (as) pair, Sc is a scale factor, ϕas(k) is the phase shift experienced by the 
photoelectron, λ is the photoelectron mean free path, and the sum is taken over all shells of scattering atoms 
included in the fit. Theoretical amplitude and phase functions, As(k) exp(−2Ras/λ) and ϕas(k), were calculated 
using FEFF v. 8.00.(29) The scale factor (Sc) and ΔE0 for Zn–N (Sc = 0.78, ΔE0 = −16 eV), Zn–S (0.85, −16 eV), Co–N 
(0.74,−21 eV), and Co–S (0.85, −21 eV) scattering were determined previously and held fixed throughout this 
analysis.(21, 27) Fits to the current data were obtained for all reasonable integer or half-integer coordination 
numbers, refining only Ras and σas2 for a given shell. Multiple scattering (ms) contributions from histidine ligands 
were approximated according to published procedures,(21, 27) fixing the number of imidazole ligands per metal 
ion at half-integral values while varying Ras and σas2 for each of the four combined ms pathways. Metal–metal 
(Co–Co and Zn–Zn) scattering was modeled by fitting calculated amplitude and phase functions to the 
experimental EXAFS of Co2(salpn)2 and Zn2(salpn)2. 
Preparation of Metal-Free IMP-1 
Recombinant IMP-1 was overexpressed and purified as described above. A dilute solution of IMP-1 (ca. 20–30 
μM) was dialyzed against 4 × 1 L (12 h per step) of 50 mM HEPES, pH 6.8, containing 10 mM 1,10-phenanthroline 
or 10 mM EDTA, at 4 °C. The chelating agent was removed by dialysis against 6 × 1 L of Chelex-treated, 50 mM 
HEPES, pH 6.8, containing 0.5 M NaCl. ICP-AES mea surements were used to determine the Zn(II) content of the 
resulting apoenzyme.(24) 
Preparation of Co(II)-Substituted IMP-1 by Direct Addition 
Metal-free IMP-1, as confirmed by ICP-AES measurements, was concentrated to ca. 1 mM by ultrafiltration. The 
concentrated enzyme was then centrifuged (10 min at 14000g) to remove precipitated protein. CoCl2 (1–2 mol 
equiv) (Strem Chemicals, 99.999% pure) was added, and the mixture was incubated for 20–30 min in ice. The 
resulting enzyme was pink in color and remained pink for weeks when stored at −80 °C. 
UV–vis Spectroscopy of Co(II)-Substituted IMP-1 
UV–vis spectra were obtained on a Hewlett–Packard 5480A UV–vis spectrophotometer measuring the 
absorbance between 200 and 800 nm at 25 °C. Background spectra of apo-IMP-1 were used to generate 
difference spectra of the Co(II)-substituted samples. 
EPR Spectroscopy on Co(II)-Substituted IMP-1 
EPR spectroscopy at cryogenic temperatures was carried out using a Bruker EleXsys E600 spectrometer 
equipped with an Oxford Instruments ESR900 helium flow system and an ITC503 temperature controller. EPR 
spectra were recorded at 9.63 GHz using an ER4116DM cavity operating in TE102 (perpendicular) mode, with 
4096 data points collected over 8000 G, and 4 G magnetic field modulation at 100 kHz. An integral microwave 
counter provided precise microwave frequencies that were found to vary within 0.0025 GHz among the samples 
examined, and resonance position reproducibility was measured to be ±2 G. Spectra were recorded over 180 s, 
and other acquisition parameters were chosen such that resolution and reproducibility were limited by the 
modulation amplitude. The temperatures and microwave powers for individual spectra are given in the legend 
to Figure 5. 
Results 
Overexpression, Purification, and Characterization of Recombinant IMP-1 
Recombinant IMP-1 was overexpressed and purified using the procedure of Laraki et al.,(30) except that 50 μM 
ZnSO4 was not included in the 50 mM HEPES (buffer A) and the previously reported MonoS chromatographic 
step was not performed. By using the procedure described in the Experimental Procedures section, high levels of 
purified IMP-1 were obtained. IMP-1 eluted from the SP-Sepharose column between 225 and 250 mM NaCl. The 
overall yield of purified IMP-1 ranged between 10 and 15 mg/L of culture, and the purity of IMP-1 was 
ascertained by SDS-PAGE to be greater than 95%. Metal analyses of recombinant IMP-1 indicated the enzyme 
binds 2.0 ± 0.3 equiv of Zn(II), and this sample was called recombinant IMP-1. MALDI-TOF mass spectrometry 
demonstrated that recombinant IMP-1 exhibits an m/z of 25 113, which is in good agreement with the molecular 
weight reported by Laraki et al. of 25 103 m/z(30) and from the deduced amino acid sequence (25 111 
amu).(7) The catalytic activity of recombinant IMP-1 was evaluated using nitrocefin as a substrate. Steady-state 
kinetic studies revealed a kcat of 135 ± 14 s–1 and a Km of 28 ± 12 (Table 1). 
Table 1. Steady-State Kinetics Parameters of Recombinant IMP-1a 
  experimental calculated 
Km (μM) 28 ± 12 30 
kcat (s–1) 135 ± 14 116 
a 
The experimental values were determined by monitoring the hydrolysis of nitrocefin in 50 mM HEPES, pH 7.5, 
and 25 °C. The calculated values were determined by using the theoretical equations for kcat and Km, given the 
reaction mechanism shown in Scheme 1(2), as determined by the King–Altman method. 
Stopped-Flow Kinetic Studies on IMP-1 
In an effort to probe the kinetic mechanism of recombinant IMP-1 for the hydrolysis of β-lactam antibiotics, 
nitrocefin was used as a substrate. Diode-array UV–vis spectra of 35 μM recombinant IMP-1 reacted with 35 μM 
nitrocefin were monitored over a 1000 ms time period between 300 and 700 nm. Two distinct absorbance 
features were identified: (1) a broad absorption band at 390 nm (corresponds to unhydrolyzed substrate) that 
decreased over time and (2) a broad absorption band at 485 nm (corresponds to hydrolyzed nitrocefin) that 
increased over time (Figure 1). There was no evidence of an additional peak at 665 nm (corresponding to an 
anionic intermediate) that was previously reported in similar studies with L1,(25) IMP-1,(31) and CcrA(32) but 
absent in studies on BcII(33) and Bla2.(19) 
 
Figure 1. Diode-array UV–vis spectra of the reaction of 35 μM IMP-1 with 35 μM nitrocefin in 50 mM HEPES, pH 
7.5, at 4 °C. Spectra were obtained every 20 ms. 
 
To further investigate the reaction mechanism of recombinant IMP-1 with nitrocefin, stopped-flow kinetic 
studies were conducted under near single turnover conditions using 35 μM IMP-1 with 35 μM nitrocefin 
(Figure 2a). Progress curves of substrate and product in Figure 2a were fitted to three possible reaction 
mechanisms (Scheme 1). Algebraic expressions for kcat and Km values for each mechanism using the King–Altman 
method(26) were used validate the best fits. While many values of the microscopic rate constants yielded 
calculated progress curves that matched the experimental data, the simplest scheme that adequately fitted the 
data and that provided theoretical kcat and Km similar to the experimental values is given in Scheme 1(1). Kinetic 
data and simulations indicate IMP-1 follows the simplest mechanism by which cleavage of the C–N β-lactam 
bond is rate-limiting. The calculated theoretical values (kcat =116 s–1, Km = 30 μM) are in excellent agreement with 
experimental values (Table 1). In further support of this kinetic mechanism, we found that 38 μM hydrolyzed 
nitrocefin inhibited by 76% the IMP-1-catalyzed hydrolysis of nitrocefin (data not shown). 
 
Figure 2. (a) Stopped-flow kinetics of the hydrolysis of nitrocefin by recombinant IMP-1. Concentrations of 
product, substrate, and intermediate were calculated as previously reported.(25) (b) Theoretical progress curves 
(lines) drawn over the experimental stopped-flow kinetic data of recombinant IMP-1. The kinetic mechanism in 
Scheme 1(1) and the rate constants—k1 = 108 M–1 s–1, k–1 = 3.0 × 103 s–1, k2 = 20 s–1, k–2 = 2.6 × 10–1 s–1, k3 = 3.3 × 
103 s–1, and k–3 = 108 M–1 s–1—were used to simulate the kinetic data. 
 
EXAFS Spectroscopic Studies on IMP-1 
EXAFS spectra were collected to probe (1) metal coordination number, (2) metal–ligand and metal–metal 
distances, and (3) amino acid ligand identity in recombinant IMP-1. EXAFS spectra were collected on three 
independently prepared samples of recombinant IMP-1. Fourier-transformed EXAFS data for recombinant IMP-1 
(Figure 3 and Figure S1) were best fitted with a mixed first shell of 4N/O + 0.5S + 0.5C (from a coordinated 
carboxylate). Inclusion of the sulfur scatterer reduced the first shell fit residual more than 4-fold, while addition 
of the carbon path further reduced it another factor of 2 (see Table S1). Multiple-scattering fits indicate an 
average of 2 His ligands per Zn(II) ion. Inclusion of a Zn–Zn vector improved the fit residual by nearly 60%. The 
refined Zn–Zn distance of 3.39 Å is in good agreement with the metal– metal separation of 3.3 Å reported by 
Yamaguchi et al.(16) The crystal structure of recombinant IMP-1(16) indicates the metal binding site is 
representative of a class B1MβL, with the Zn1 site composed of three His ligands and the Zn2 site defined by one 
His, one Cys, one Asp, and a terminal water ligand. The two metals are bridged by a solvent molecule, leading to 
an average Zn site of 4N/O + 0.5S donors, including 2 His ligands per Zn(II), and the EXAFS are consistent with 
this picture (Table 2). The metal–ligand distances determined by EXAFS are all in reasonable agreement with 
those reported in the crystal structure. 
 
Figure 3. Fourier-transformed EXAFS of Zn(II)- and Co(II)-containing IMP-1 (solid lines) and corresponding best 
fits (open symbols). See Table 2, Tables S1–S3, and Figures S1–S5 for details. 
 
Table 2. Best Fits to EXAFS of Zn(II) and Co(II)-Containing IMP-1a 
model M–N/O M–S M–C M–Hisb M–M 
recombinant IMP-1           












IMP-1 with 1 Zn(II)           








2.89 (4.9), 3.11 (4.6), 4.02 (8.0), 
4.42 (6.6) 
  
IMP-1 with 2 Zn(II)           












IMP-1 with 1 Co(II)           








IMP-1 with 2 Co(II)           








aDistances (Å) and disorder parameters (in parentheses, σ2 (10–3 Å2)) shown derive from integer or half-integer 
coordination number fits to filtered EXAFS data [Δk = 1.5–13 Å–1 (Zn) or 1.5–12.4 Å–1 (Co); ΔR = 0.3–4.3 Å]. 
See Tables S1–S3 and Figures S1–S5 for detailed fits. 
bMultiple scattering paths represent combined paths, as described previously (see Experimental Procedures). 
 
Preparation and Characterization of Co(II)-Substituted IMP-1 by Direct Addition 
In order to structurally characterize IMP-1 further, Co(II)-substituted analogues were prepared and 
characterized. Two direct addition methods were attempted in preparing Co(II)-substituted IMP-1. The initial 
step in each method required the preparation of metal-free enzyme. Chelators 1,10- phenanthroline and EDTA 
were used during this step. The use of 1,10-phenanthroline resulted in substantial precipitation of dilute (20 μM) 
and concentrated (ca. 1 mM) samples after the first dialysis step. As a result, EDTA was used in all remaining 
preparations of metal-free IMP-1, following the procedure described in Experimental Procedures. ICP-AES 
measurements on multiple apo-IMP-1 samples demonstrated undetectable levels of Zn, Co, Fe, or Mn. 
Apo-IMP-1 samples were concentrated to ca. 1 mM by ultrafiltration. The concentrated enzyme was then 
centrifuged to remove precipitated protein. CoCl2 or ZnCl2 (1–2 mol equiv) was added, and the mixture was 
incubated for 20–30 min on ice. The Co(II)-treated enzyme was pink in color and remained pink for weeks when 
stored at −80 °C. 
Steady-State Kinetics of Metal-Substituted IMP-1 
To ascertain the catalytic activity of the metal-substituted enzymes (IMP-1 samples containing 1 or 2 equiv of 
Zn(II) and Co(II)), steady-state kinetic constants were determined using nitrocefin as a substrate in 50 mM 
HEPES, pH 6.8, and the resulting values were compared to those of as-isolated, ZnZn-IMP-1 (Table 3). The 
samples containing 1 equiv of Zn(II) or Co(II) exhibited roughly 50% the activity of the dinuclear enzymes. 
The Km values exhibited by the three dinuclear forms (as-isolated-, ZnZn-, and CoCo-IMP-1) were identical within 
error, while the Km values of the samples containing 1 equiv of Zn(II) and Co(II) were slightly lower. There was a 
slight decrease in kcat values of the metal-added samples as compared to that of the as-isolated enzyme, most 
likely due to small amounts of protein being denatured as metal ion stocks are added to the apoenzyme. 
Table 3. Steady-State Kinetic Constants of IMP-1 Analogues Made by Direct Addition of Metal to Apo-IMP-1 
  recombinant IMP-
1 








Km (μM) 28 ± 12 12 ± 5 25 ± 7 18 ± 5 29 ± 7 
kcat (s–1) 135 ± 14 35 ± 4 105 ± 10 70 ± 7 113 ± 11 
kcat/Km(μM–1 s–
1) 
4.8 2.9 4.2 3.9 3.9 
 
Spectroscopic Characterization of Co(II)-Substituted IMP-1 
UV–vis difference spectra (spectra of the Co-bound samples minus the spectrum of apo-IMP-1) were obtained 
for the IMP-1 analogues containing 1 and 2 equiv of Co(II). The addition of 1 equiv of Co(II) to apo-IMP-1 
resulted in a broad absorption peak at 340 nm and additional peaks between 500 and 600 nm (Figure 4). The 
feature observed near 340 nm (ε340 nm = 155 M –1 cm–1) is assigned to a Cys-S Co(II) ligand-to-metal charge 
transfer transition,(23, 32, 34) which strongly suggests cobalt binding at the consensus Zn2 site. In addition, the 
broad peak at 550 nm (ε550 nm= 63 M–1 cm–1) is assigned to ligand field transitions of high-spin Co(II).(35) The 
magnitudes of the extinction coefficient of these peaks suggest a ligand coordination number of 5/6. The 
addition of a second equivalent of Co(II) to the sample results in a spectrum showing an increase in the 
intensities of both features (ε550 nm= 95 M–1 cm–1, ε340 nm= 256 M–1 cm–1). These results suggests Co(II) is 
distributed between both binding sites in both Co(II)-containing samples. 
 
Figure 4. UV–vis difference spectra of IMP-1 containing 0.9 equiv of Co(II) (bottom spectrum) and 1.9 equiv of 
Co(II) (top spectrum). The enzyme concentration was 0.840 mM in 50 mM HEPES, pH 6.8, containing 0.5 M NaCl. 
 
EXAFS studies were conducted on Zn(II)- and Co(II)-reconstituted analogues of IMP-1 (Figure 3 and Figures S2–
S5; Table 2 and Table S2). For IMP-1 containing 1 equiv of Zn(II) (Figure S2 and Table S2), the EXAFS data are best 
fitted with a mixed first shell of 4N/O + 0.5S + 0.5C. Inclusion of the sulfur path reduced the fit residual by 88%, 
while addition of the Zn–C path decreased it 64% further, suggesting both a sulfur (Cys) and a carboxylate 
carbon are part of the primary coordination sphere of the first added equivalent of zinc. Multiple-scattering fits 
indicate an average of 2 histidines per Zn, which suggests that the first equivalent of Zn(II) is distributed 
between the two binding sites. Addition of Zn–Zn scattering path did not significantly improve the fit residual 
(only 12%), and it refined to an unreasonably short distance of 3.23 Å, indicating the lack of a metal–metal 
interaction with one added equivalent of Zn(II). These data do not indicate cooperativity in Zn(II) binding. 
Addition of a second equivalent of Zn(II) leads to a model that is indistinguishable from that obtained for 
recombinant IMP-1 (Figure S3 and Table S2). 
In contrast, EXAFS data of IMP-1 with 1 equiv of added Co(II) (Figure 3 and Figure S4, Table 2 and Table S3) are 
best fitted with a model that appears to indicate an intact dinuclear cluster. The model includes 4N/O + 0.5S 
ligands in the primary coordination sphere, without showing evidence of the carboxylate carbon. Multiple-
scattering fits indicate an average of 2 histidines per Co(II), and inclusion of a Co–Co vector reduces the fit 
residual by 33%, refining to a reasonable distance of 3.42 Å. The same model produced the best fit to the EXAFS 
data for IMP-1 containing 2 equiv of added Co(II) (Figure 3 and Figure S5, Table 2 and Table S3), including a Co–
Co distance of 3.45 Å that led to a 39% decrease in the fit residual. The Co–Co distance for IMP-1 containing 2 
added equivalents of Co(II) is slightly longer than that obtained with 1 added equivalent of Co(II) (3.45 Å vs 3.42 
Å). In both cases, the average Co–N/O distance is ca. 0.06–0.08 Å longer than the corresponding Zn–N/O 
distance, which may reflect an increase in average coordination number for Co(II). 
The EPR spectrum of IMP-1 containing 1 equiv of Co(II) exhibited a complex S = 3/2, MS = |±1/2⟩ signal that was 
unsaturated at 8 K and 0.2 mW but could not be simulated as a single species (Figure 5A). This result indicated at 
least two distinct Co(II) species, each either 5- or 6-coordinate.(36) Some barely resolved 59Co hyperfine 
structure was observed on the maximum feature at around 1300 G (130 mT), but the lines were otherwise 
broad, suggesting coordination by one or more solvent molecules in addition to the protein-derived ligands. 
Spectra of IMP-1 containing 1 equiv of Co(II) at different pH values (Figure 5A–C) suggested a pH-dependent 
equilibrium between at least two species, one of which exhibited some 59Co hyperfine splitting of the low field 
absorption (1000–1500 G; 100–150 mT) at the higher pH values (compare traces A–C of Figure 5) with A(59Co) ∼ 
6.5 × 10–3 cm–1. This result may indicate either a Co–OH/Co–OH2 equilibrium or else a pH-dependent mixture of 
a 5- and 6-coordinate species that differ in the number of coordinated solvent molecules. At higher microwave 
power and lower temperature (5.5 K, 100 mW), the MS = |±1/2⟩ signal was distorted by rapid-passage effects, 
and an additional, faster-relaxing narrow absorption feature at 1050 G (105 mT, geff = 6.5) was detectable, 
characteristic of an MS = |±3/2⟩ signal and due to tetrahedral Co(II) (Figure 5B). Interestingly, the rapid passage 
effects on the MS = |±1/2⟩ signal appeared to be more apparent at lower pH, suggesting that lower pH favors 6-
coordinate rather than 5-coordinate Co(II). The intensity of the MS = |±3/2⟩ signal relative to the MS = |±1/2⟩ 
signal increased with increasing pH, again suggesting that lower coordination numbers are favored at higher pH 
values, whereas lower pH values favor higher coordination, presumably due to additional coordination by 
solvent molecules. Upon addition of a second Co(II) ion, the enzyme yields a spectrum (Figure 5C) under 
nonsaturating conditions that is higher in intensity than that of IMP-1 containing 1 equiv of Co(II) but otherwise 
similar to, though not superimposable with, that of IMP-1 containing 1 equiv of Co(II). A difference spectrum 
(Figure 5E) indicates that upon addition of the second Co(II) ion the amount of a broad MS = ±1/2 axial species, 
devoid of resolved 59Co hyperfine structure and with no well-resolved g′z feature, increases relative to that of 
the second species with resolved g′ resonances and partially resolved 59Co hyperfine structure. It is unclear 
whether the species that is more dominant at higher levels of Co(II) is due to a distinct 5- or 6-coordinate Co(II) 
ion with solvent coordination or whether the poor resolution of g′ resonances and lack of hyperfine structure is 
a consequence of dipolar broadening due to Co(II)–Co(II) interactions in dinuclear centers. Parallel mode studies 
in the TE012 cavity mode showed no evidence for the weak exchange coupling that is often observed for 
dinuclear Co(II) centers in substituted dinuclear metallohydrolases,(36) but some dipolar coupling is to be 
expected. The magnitude of the dipolar interaction is likely small compared to the line width for the MS = 
±1/2 signals, and the precise effect on the spectra is sensitive to the relative orientations of the g-tensors and the 
interspin vector(37) and will differ in individual molecules depending on the precise nature of the electronic 
structure of the two Co(II) ions which, in turn, will depend on chemical factors such as the degree of solvent 
coordination and the protonation state of coordinated solvent. Detailed pH dependence and 1H electron–
nuclear double resonance studies will be required to address further the natures of the putative species and 
their equilibria. Some information, however, is available from the spectrum of IMP-1 with two added Co(II) ions, 
recorded at 5.5 K and 100 mW (Figure 5D). The spectrum suggests that the tetrahedral (MS = ±3/2) site is filled, 
on aggregate, before the higher coordinate site, indicating that the cooperativity of Co(II) binding to IMP-1, 
while substantial, is not absolute. These data for IMP-1 contrast markedly with those from another B1 enzyme, 
CcrA.(21) In that enzyme, the binding is highly sequential, and the two distinct sites each exhibit EPR, EXAFS, and 
optical absorption spectra that indicate 5- or 6-fold coordination of Co(II), presumably due to additional solvent 
coordination, whereas a tetrahedral site and positively cooperative binding are indicated in IMP-1. 
 
Figure 5. Experimental EPR spectra of Co(II)-containing IMP-1: (A) IMP-1 containing 1 equiv of Co(II), 0.2 mW, 
13K; (B) IMP-1 containing 1 equiv of Co(II), 100 mW, 5K; (C) CoCo-IMP-1, 0.2 mW, 13K; (D) CoCo-IMP-1, 100 mW, 
5K. (E) Difference spectrum, CoCo-IMP-1 minus IMP-1 containing 1 equiv of Co(II), 0.2 mW, 13K. 
 
Discussion 
Bacterial resistance to antibiotics is an alarming medical crisis.(38) The misuse of current antibiotics and the 
rapid dissemination of resistance genes via conjugation/horizontal gene transfer have resulted in infections, 
once treated with inexpensive antimicrobial agents, that are no longer treatable. The largest class of antibiotics 
is the β-lactam containing agents; however, the emergence and spread of certain β-lactamases have made many 
of these β-lactam containing antimicrobial agents not as effective as in the past.(3, 39) IMP metallo-β-
lactamases (and variants) are one such group of β-lactamases that hydrolyze almost all known β-lactam-
containing antibiotics.(8) The genes for the IMP variants readily transfer among other bacterial strains, thereby 
reducing the number of β-lactam susceptible strains. One strategy to combat β-lactam resistance is to utilize 
antibiotics from other classes, such as the quinolones and macrolides. Unfortunately, clinical resistance to these 
alternative antibiotics is already evident, leaving very few options to treat bacterial infections.(1) A second 
strategy that has been used previously to combat β-lactam resistance, specifically caused by certain serine-β-
lactamases, is the production of β-lactamase inhibitors, such as tazobactam and clavulanic acid.(40) These 
inhibitors are given in combination with existing β-lactam containing antibiotics to combat resistant bacterial 
strains. Unfortunately, none of the existing β-lactamase inhibitors can be used in the clinic to combat metallo-β-
lactamases like IMP-1. Therefore, there is considerable interest in identifying clinically useful inhibitors against 
the metallo-β-lactamases.(8, 15, 41-47) One strategy to prepare these inhibitors is to structurally and 
mechanistically characterize the enzymes in an effort to rationally design inhibitors. In studies on L1 and ImiS, 
spectroscopic studies, in combination with rapid freeze quench technology and Co(II)-substituted analogues of 
the enzymes, have been used to interrogate the mechanism as substrate is converted to product.(20, 48, 
49) The first step in conducting these spectroscopic studies is to successfully prepare active, well-characterized 
Co(II)-substituted analogues of the native Zn(II)-containing enzyme. This work describes our efforts at preparing 
and characterizing the Co(II)-substituted analogue of IMP-1. 
The overexpression and purification of recombinant IMP-1 have been reported by several groups, and the 
purification procedures, when specified, involved multiple chromatographic steps.(5, 30, 41, 50-52) The 
purification of IMP-1 presented herein required a single chromatographic step, and protein yields were similar 
to those reported earlier. The kcat value of recombinant IMP-1 (Table 1) was 2-fold higher than reported by 
Laraki but 1.4-fold lower, after normalizing for different assay temperatures, than the values reported by 
others.(30, 45, 51, 52) The higher kcat (and corresponding kcat/Km) values reported by 
Siemann,(45) Materon,(51) and Oelschlaeger(52) were obtained in assays that contained 50–100 μM Zn(II) and 
bovine serum albumin, and both of these additives likely maintained larger amounts of active ZnZn–IMP-1. 
The Km value of recombinant IMP-1 (Table 1) is identical to that reported by Laraki, but 2–3-fold larger than 
previously reported by others.(30, 45, 51, 52) Our larger values for Km are likely due to our excluding extra Zn(II) 
in the IMP-1 samples used in our steady-state kinetic assays, as previously observed in studies with L1.(24) The 
metal content of recombinant IMP-1 purified as described in Experimental Procedures was 2 equiv, which is 
similar to that reported by Laraki.(30) Many of the other reports of overexpression and purification of IMP-1 did 
not report metal content. Differing buffers and pH’s(9, 45, 52) and added Zn(II) (and bovine serum albumin) in 
assay buffers(51, 52) undoubtedly contributed to the differences in the steady-state kinetics. 
β-Lactamase hydrolysis of the β-lactam ring involves two steps: a nucleophilic attack on the carbonyl group and 
C–N bond cleavage; however, these reactions may be concerted in some enzymes.(53) Previous mechanistic 
studies on dinuclear MβLs CcrA and L1, using nitrocefin as a substrate, concluded that the rate-limiting step was 
protonation of anionic, ring-opened intermediate formed during catalysis.(25, 54) Similar kinetic studies on Bla2 
and BcII showed that the nitrocefin-derived reaction intermediate was not observed,(19, 33) and Vila suggested 
that the absence of this intermediate might be due to the relatively short loop that covers BcII’s active 
site.(33) Similar studies on IMP-1 are conflicting. Moali et al. reported that small amounts of intermediate were 
formed and that the reaction rate was so fast that it was difficult to accumulate significant amounts of the 
intermediate.(31) On the basis of these results, Moali suggested a kinetic mechanism similar to those of L1 and 
CcrA and reported the simulated rate constants based on that mechanism. On the other hand, Yamaguchi et al. 
reported that no intermediate is formed.(16) In the present study, stopped-flow kinetic studies were conducted 
on IMP-1 in an effort to resolve the conflicting data. There was no peak at 665 nm, corresponding to a reaction 
intermediate, observed in our data (Figure 1), and we could not detect a peak by lowering the temperature of 
the water bath or by varying the enzyme and substrate concentrations (data not shown). Therefore, we 
conclude that the anionic intermediate, previously observed in studies on L1 and CcrA,(25, 54) is not observed in 
the rapid kinetic studies on recombinant IMP-1, consistent with results reported by Yamaguchi.(16) The rapid 
kinetic data on recombinant IMP-1 was simulated using a simple Michaelis kinetic scheme,(26) and microscopic 
rate constants are reported. Importantly, this scheme was used to derive theoretical kinetic constants, and the 
resulting theoretical values (Table 1) for kcat and Km are very similar to those determined from experiments. 
Since the loop in IMP-1 is relatively larger than that in BcII,(55) the loop alone cannot explain the absence of the 
anionic intermediate in the enzymes. An examination of several MβL active sites shows subtle differences in the 
positions of metal binding ligands and major differences in nonmetal binding regions around the metal binding 
sites. In fact, the regions around the metal binding sites in L1 and CcrA, both of which stabilize the anionic 
intermediate, are very different. It is clear that presence of the reactive intermediate must be accompanied by 
precise orientations of ligands around the active site.(56) 
Compared to L1, CcrA, ImiS, and BcII, there have been very few spectroscopic studies reported on IMP-1 or on 
any of the IMP variants. This lack of data could possibly be due to the inability to reconstitute apo-IMP-1 with 
metal ions.(30, 45, 57) By using the procedure as described in Experimental Procedures, Co(II)-substituted IMP-1 
and reconstituted ZnZn–IMP-1 can now be prepared and used in spectroscopic studies. EXAFS studies were 
conducted on the as-isolated ZnZn–IMP-1 so that these results could be compared to those on the metal-
reconstituted samples. The EXAFS data yielded metal–metal and metal–ligand distances that are in excellent 
agreement with those previously reported in crystal structures.(14, 16) In addition, EXAFS studies on 
reconstituted ZnZn–IMP-1 yielded identical values for metal–metal and metal–ligand distances, which 
demonstrates that the metal-reconstitution/substitution method described herein yields the same enzyme as 
isolated, which is supported by the steady-state kinetic studies (Table 3). 
The direct addition of Co(II) or Zn(II) to apo-MβLs can result in three possible metal binding modes: (1) 
sequential (metal binds to the Zn1 site and then to the Zn2 site; activity is variable depending on the activity of 
the mononuclear enzyme, (2) positive cooperative (the binding of the first metal equivalent increases the 
affinity for the binding of a second equivalent of metal: addition of 1 equiv of metal results in a mixture of 50% 
apoenzyme and 50% fully loaded enzyme and in roughly 50% activity; (3) random (the metal distributes between 
both sites; very difficult to predict the activity of the resulting mixture). Steady-state kinetics were conducted 
prior to the spectroscopic studies to confirm that the Co(II)-substituted analogues retain catalytic activity 
(Table 3). The mono- and binuclear analogues of IMP-1 all exhibited activity (Table 3). In general, the steady-
state kinetic studies suggest that metal binding to IMP-1 follows a positive cooperative mode. IMP-1 containing 
1 equiv of Zn(II) exhibits a kcat that is roughly 50% of that for the as-isolated enzyme. IMP-1 containing 1 equiv of 
Co(II), however, exhibits a kcat that is only 33% of that for the CoCo–IMP-1 analogue. This lower kcat for IMP-1 
containing 1 equiv of Co(II) is probably due to some oxidation of the Co(II) after adding the metal to the dilute 
apoenzyme sample. This lower kcat value for IMP-1 containing 1 equiv of Co(II) probably explains why this 
analogue’s kcat/Km value is lower than that of the other analogues (Table 3). The Km values, which have been 
confirmed with at least 10 different preparations of the analogues, for the IMP-1 analogues containing only 1 
equiv of metal ion are significantly lower than those for the analogues containing 2 equiv of metal ions (Table 3). 
This result is not expected for positive cooperative binding of metal, which would result in a Km value that is 
identical to that of the dinuclear metal ion containing analogue. We currently do not know why the analogues 
containing 1 equiv of metal ion exhibit lower Km values; however, it may be due to the relatively low 
concentrations of the enzyme (10–30 nM) with respect to the concentration of adventitious Zn(II) in our buffers 
(100–200 nM).(20) Wommer et al. previously hypothesized that substrate activates the binding of 
Zn(II);(58) therefore, it is possible that a substrate–Zn(II) complex could bind better to the apoenzyme, resulting 
in an apparent lower value for Km. 
Spectroscopic studies on IMP-1 support positive cooperative binding of Co(II) to the enzyme. UV–vis 
spectroscopy on Co(II)-substituted IMP-1 revealed two distinct absorbance peaks with the addition of 1–2 equiv 
to apo-IMP-1 (Figure 4). The feature observed near 340 nm is attributed to a ligand (Cys-S) to metal charge 
transfer band. Cys221, in the concensus Zn2 site,(13, 59) coordinates Co(II) when 1 equiv of the metal binds, and 
Cys-S coordination increases as the second equivalent of Co(II) is added. EXAFS spectra on IMP-1 containing 1 
equiv of Co(II) are best fitted including a metal–metal contribution, suggesting that metal ions occupy both the 
Zn1 and Zn2 sites in the enzymes containing only 1 equiv of metal ion. While the EXAFS fits did not significantly 
improve with including a metal–metal interaction for IMP-1 containing 1 equiv of Zn(II), it is very likely that this 
sample also exhibits positive cooperativity, given the steady-state kinetic data (Table 3). Likewise, EPR spectra 
on Co(II)-substituted IMP-1 samples strongly support positive cooperative metal binding to IMP-1. These results 
suggest that there are mixtures of fully loaded and apo-IMP-1 upon addition of 1 equiv of metal ion. 
Previous studies on other MβLs have shown that CcrA exhibits positive cooperative(60) or sequential(61) Zn(II) 
binding and sequential Co(II) binding.(21) L1(20) and Bla2(19) exhibit mostly sequential and 
sequential/distributed metal binding, respectively. Reports dealing with metal binding to BcII have varied 
substantially with several groups reporting sequential binding(23, 62-66) and one group reporting 
noncooperative Zn(II) binding with a subsequent dimerization of the enzyme.(67) Another report on BcII 
suggested positive cooperative binding,(68) and several groups have recently reported that the only active form 
of BcII is the dinuclear metal ion containing form,(69-71) suggesting positive cooperative binding. Careful 
titration of BcII with Co(II) has demonstrated mixtures of apo-, mono-, and dinuclear metal ion containing forms, 
even in the presence of low levels of Co(II).(72) These latter studies suggest a complex equilibrium process for 
metal binding to BcII but favor, in part, some positive cooperative Co(II) binding to BcII. The data presented 
herein suggest that IMP-1 exhibits positive cooperative binding of both Zn(II) and Co(II). The ability to prepare 
metal-substituted analogues of IMP-1 will now allow for future rapid-freeze quench spectroscopic studies to 
probe the reaction mechanism of the enzyme. Information gleaned from these studies will allow for the design 
of mechanism-based inhibitors. 
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